Mobile App

Google Play Apple Store
ACC Conference Coverage: Clinical Clips in Heart Failure
Heart failure (HF) is a complex syndrome and a growing problem, in terms of both the number of patients affected, its associated clinical consequences and its implications for health care expenditure. HF is recognized as the ultimate pathway of cardiovascular disease (CVD). Importantly, rapid ageing of the population means that the incidence of HF shall increase further in the coming years. Preventing the development of this condition in the population at large, in order to reduce hospital readmission rates, its other clinical sequelae and its economic consequences, is a key issue in modern medicine. Appropriate HF treatment can have the greatest influence on prolonging patients' lives in the coming year. Typically, HF is a common and insidious disease with substantial associated morbidity and mortality burden worldwide. This has led to a significant focus on improving treatments and medical therapy for this condition.

This podcast will provide expert interpretation of recent clinical trial evidence for CV risk reduction in people with HF, examining results of new therapeutic approaches for the treatment of HF presented at the 73rd Annual Scientific Session & Expo of American College of Cardiology (ACC 2024), April 6-8, Atlanta, GA.
Review the activity to claim AMA/ABS/ANCC/ACPE credit after completion of the brief Post-Test/Evaluation(s).

Peter P. Toth, MD, PhD, FCCP, FESC, FAHA, FACC Peter P. Toth, MD, PhD, FCCP, FESC, FAHA, FACC
Director of Preventive Cardiology
CGH Medical Center
Professor of Clinical Family and Community Medicine
University of Illinois School of Medicine
Adjunct Professor of Medicine
Division of Cardiology
Johns Hopkins University School of Medicine

Supported by an independent educational grant from Merck Sharp & Dohme LLC

Launch Date: April 11, 2024
Release Date: April 11, 2024
Expiration Date: March 31, 2025

Mini Module


Change Settings